Latest Period
Q1 2026
Security Snapshot
Guardant Health, Inc. - COMMON STOCK (GH) Institutional Ownership
CUSIP: 40131M109
13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026
Institutions Reporting
480
Shares (Excl. Options)
135,293,841
Price
$92.37
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- GH on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 135,293,841
- Total 13F value
- $12,504,177,793
- Portfolio coverage rank
- 0.01%
- Share change
- +3,926,288
- Value change
- +$304,788,671
- Number of holders
- 480
- Shares outstanding
- 130,292,056
- SEC-reported price per share
- $98.47
- Insider filing price
- $98.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- GH - Guardant Health, Inc. - COMMON STOCK is tracked under CUSIP 40131M109.
- 480 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 494 to 480 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $13,385,773,328 to $12,504,177,793.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 480 institutions filings for Q1 2026.
Security key
40131M109
Latest holder period
Q1 2026
13F holders
480
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
GH full holder history
Guardant Health, Inc. SEC filings
Guardant Health, Inc. company facts
Guardant Health, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 40131M109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
GH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.5% | $460,074,314 | 9,288,801 | BlackRock, Inc. | 31 Mar 2025 | |||
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.4% | $613,308,158 | 7,035,771 | T. Rowe Price Associates, Inc. | 31 Mar 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $608,662,324 | 6,589,394 | Vanguard Capital Management | 31 Mar 2026 | |||
| Deep Track Capital, LP | 4.4% | $269,627,501 | 5,443,721 | Deep Track Capital, LP | 31 Mar 2025 | |||
| CADIAN CAPITAL MANAGEMENT, LP | 4.2% | $258,624,114 | 5,221,565 | Cadian Capital Management, LP | 31 Dec 2024 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 3.9% | $240,233,923 | 4,850,271 | Wellington Management Group LLP | 31 Dec 2024 |
As of 31 Mar 2026, 480 institutional investors reported holding 135,293,841 shares of Guardant Health, Inc. - COMMON STOCK (GH). This represents 104% of the company’s total 130,292,056 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.9% | 11,553,759 | +2.1% | 0.02% | $1,067,220,736 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.4% | 7,023,689 | +25% | 0.08% | $648,779,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5% | 5,837,992 | 0% | 0.03% | $539,255,321 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 5,624,180 | 0% | 0.01% | $519,505,507 |
| Invesco Ltd. | 3.8% | 4,946,469 | -7% | 0.07% | $456,905,368 |
| GOLDMAN SACHS GROUP INC | 3.4% | 4,435,839 | +69% | 0.05% | $409,738,481 |
| TWO SIGMA INVESTMENTS, LP | 3.2% | 4,229,531 | +95% | 0.32% | $390,681,778 |
| FMR LLC | 3.2% | 4,116,081 | +72% | 0.02% | $380,202,437 |
| BAILLIE GIFFORD & CO | 3% | 3,859,046 | -21% | 0.36% | $356,460,078 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 3,508,883 | +9.2% | 0.02% | $324,172,637 |
| Capital International Investors | 2.7% | 3,481,318 | -1.3% | 0.08% | $321,569,344 |
| FRANKLIN RESOURCES INC | 2.6% | 3,448,193 | +2.6% | 0.08% | $318,509,548 |
| Deep Track Capital, LP | 2.6% | 3,338,241 | +19% | 6.4% | $308,353,321 |
| STATE STREET CORP | 2.2% | 2,884,620 | +3.2% | 0.01% | $266,452,349 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2% | 2,550,314 | +4.4% | 0.79% | $235,572,468 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.8% | 2,362,379 | -5.9% | 3.6% | $218,087,540 |
| ALLIANCEBERNSTEIN L.P. | 1.5% | 1,905,637 | +0.23% | 0.06% | $194,641,763 |
| LORD, ABBETT & CO. LLC | 1.5% | 1,899,113 | -4.5% | 0.57% | $175,421,000 |
| FEDERATED HERMES, INC. | 1.4% | 1,887,584 | -7.1% | 0.28% | $174,356,133 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.2% | 1,623,511 | -15% | 0.03% | $149,963,711 |
| Driehaus Capital Management LLC | 1.2% | 1,524,282 | -29% | 1% | $140,797,928 |
| Alyeska Investment Group, L.P. | 1.1% | 1,489,566 | +11% | 0.39% | $137,591,211 |
| MORGAN STANLEY | 1.1% | 1,487,324 | +29% | 0.01% | $137,384,260 |
| RTW INVESTMENTS, LP | 1.1% | 1,481,033 | 0% | 1.4% | $136,803,018 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 1,451,803 | -0.4% | 0.02% | $134,103,043 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q1 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 135,293,841 | $12,504,177,793 | +$304,788,671 | $92.37 | 480 |
| 2025 Q4 | 131,065,813 | $13,385,773,328 | +$814,528,443 | $102.14 | 494 |
| 2025 Q3 | 122,493,323 | $7,653,044,062 | -$62,866,800 | $62.48 | 388 |
| 2025 Q2 | 124,295,969 | $6,467,826,507 | +$330,760,770 | $52.04 | 359 |
| 2025 Q1 | 118,497,703 | $5,048,168,027 | +$16,046,986 | $42.60 | 336 |
| 2024 Q4 | 119,495,658 | $3,649,677,643 | -$152,886,448 | $30.55 | 294 |
| 2024 Q3 | 124,539,664 | $2,855,453,478 | +$192,800,636 | $22.94 | 264 |
| 2024 Q2 | 114,848,348 | $3,316,872,682 | +$179,592,491 | $28.88 | 274 |
| 2024 Q1 | 111,383,571 | $2,296,334,142 | -$29,707,645 | $20.63 | 252 |
| 2023 Q4 | 110,309,454 | $2,983,894,470 | +$45,961,733 | $27.05 | 289 |
| 2023 Q3 | 108,297,993 | $3,210,080,906 | -$83,646,730 | $29.64 | 289 |
| 2023 Q2 | 110,144,879 | $3,943,258,288 | +$694,610,966 | $35.80 | 293 |
| 2023 Q1 | 92,579,337 | $2,168,850,990 | -$17,004,713 | $23.44 | 271 |
| 2022 Q4 | 94,289,245 | $2,564,763,814 | -$199,503,944 | $27.20 | 280 |
| 2022 Q3 | 94,962,606 | $5,108,852,818 | +$162,272,236 | $53.83 | 310 |
| 2022 Q2 | 92,768,225 | $3,745,003,930 | -$39,996,274 | $40.34 | 310 |
| 2022 Q1 | 92,443,619 | $6,110,748,734 | -$81,915,249 | $66.24 | 335 |
| 2021 Q4 | 92,085,897 | $9,209,883,362 | -$251,467,115 | $100.02 | 379 |
| 2021 Q3 | 94,130,065 | $11,765,302,482 | +$583,304,963 | $125.01 | 365 |
| 2021 Q2 | 89,577,134 | $11,124,047,648 | -$275,498,694 | $124.19 | 410 |
| 2021 Q1 | 91,351,911 | $13,941,648,366 | +$681,296,473 | $152.65 | 410 |
| 2020 Q4 | 87,374,557 | $11,260,127,731 | +$219,249,861 | $128.88 | 399 |
| 2020 Q3 | 85,443,260 | $9,550,543,816 | +$176,117,596 | $111.78 | 341 |
| 2020 Q2 | 84,323,375 | $6,840,933,865 | +$491,051,528 | $81.13 | 311 |
| 2020 Q1 | 78,329,707 | $5,451,350,483 | +$31,071,063 | $69.60 | 281 |